Alembic Pharma Receives USFDA Final Approval for Macitentan Tablets, 10 mg
Alembic Pharmaceuticals Ltd. has received final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Macitentan Tablets, 10 mg.
Actelion Pharmaceuticals US | 20/08/2025 | By Dineshwori | 368
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy